• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

    9/26/24 6:05:00 AM ET
    $DOCS
    $RELY
    $LVGO
    EDP Services
    Technology
    Business Services
    Consumer Discretionary
    Get the next $DOCS alert in real time by email

    With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics

    Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures.

    The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to patients is hampered by healthcare provider shortages and rising costs. This problem is especially pronounced for highly prevalent, commonplace procedures that exist along most patient journeys between initial consultation and recovery – critical procedures such as biopsies, organ and vascular access, and pain management interventions. Here in the "messy middle" of healthcare, where demand is high and skills are deceptively hard to acquire, a scarcity of experienced proceduralists results in care bottlenecks and increased costs. While other industries have addressed similar dynamics by deploying robotics to improve quality and workforce productivity, robots in healthcare thus far have primarily been limited to high-end, singularly focused surgeries.

    Mendaera is pioneering a new category in medical robotics, making advanced technologies readily available for these foundational everyday procedures. Its handheld interventional platform includes robotics, AI, real-time imaging, and virtual connectivity, and is designed to be accessible across specialties and sites of service to empower providers and systems to better meet the growing demand for needle-based interventions. By better distributing care for this ubiquitous yet often-overlooked category of procedures, Mendaera aims to improve hundreds of millions of patient encounters per year and drive systemwide efficiencies.

    "Traditional surgical robots have established footing in the operating room," said Josh DeFonzo, Founder and CEO of Mendaera. "But robotics and AI have evolved to a point where we can deliver broader benefits across all parts of the healthcare system and enable higher standards of care for more patients. We believe that our technology will allow healthcare systems and providers to provision medical procedures at scale – enhancing patient experience, increasing access to high-quality care, reducing overall cost, and improving healthcare provider satisfaction."

    "Mendaera has the unique ability to improve the patient experience and make high-quality care widely accessible," said Emily Melton, Founder and Managing Partner at Threshold Ventures. "Amidst rising healthcare costs and labor shortages impacting quality and affordability, it is imperative to harness advanced technology to revolutionize healthcare delivery. We are thrilled to join forces with the dynamic Mendaera team, comprising the most innovative and accomplished leaders in medical robotics and software."

    Mendaera will utilize the new funding to complete development of its robotic technology, accelerate development of its AI and connectivity capabilities, and begin clinical introduction of its platform. Earlier this year, Mendaera announced that it had acquired the telepresence technology of Avail Medsystems to expand its portfolio to include virtual connectivity. In 2023, Mendaera announced a commercial agreement with the point-of-care ultrasound company Butterfly Network.

    About Mendaera

    Mendaera's vision is to digitize clinical judgment and technical expertise, making high-quality care available for every patient at every care facility. Its platform in development combines robotics, AI, real-time imaging, and connectivity, to enable intervention at scale. Based in Silicon Valley, Mendaera is backed by leading investors and includes a leadership team successful in taking early-stage medical technology companies through to successful exits including Auris Health. Mendaera's robotic system has not been cleared by the FDA for sale in the United States.

    About Threshold Ventures

    Threshold Ventures is an early-stage venture capital firm helping founders in healthcare and enterprise software bring their ideas to market. Our investments include BetterUp, Brightline, Doximity (NYSE:DOCS), LaunchDarkly, Livongo (NASDAQ:LVGO), Remitly (NASDAQ:RELY), Rippling, Talkdesk, and Viz.ai. Based on our work with these and dozens of other startups, we purpose-built Threshold so we can be the most effective partner for entrepreneurs at the early stages of building their companies. Learn more at www.threshold.vc.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20240926902349/en/

    Get the next $DOCS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DOCS
    $RELY
    $LVGO

    CompanyDatePrice TargetRatingAnalyst
    Remitly Global Inc.
    $RELY
    5/8/2025$30.00 → $32.00Buy
    Monness Crespi & Hardt
    Doximity Inc.
    $DOCS
    2/7/2025$31.00 → $78.00Neutral → Overweight
    Piper Sandler
    Doximity Inc.
    $DOCS
    2/7/2025$60.00 → $90.00Market Perform → Outperform
    Leerink Partners
    Doximity Inc.
    $DOCS
    12/20/2024$55.00Equal-Weight
    Stephens
    Doximity Inc.
    $DOCS
    12/4/2024$55.00Neutral
    Mizuho
    Doximity Inc.
    $DOCS
    11/15/2024$58.00Neutral
    Goldman
    Doximity Inc.
    $DOCS
    11/14/2024$33.00 → $53.00Underweight → Equal-Weight
    Morgan Stanley
    Doximity Inc.
    $DOCS
    11/13/2024$40.00 → $60.00Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $DOCS
    $RELY
    $LVGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Morris Nigel W bought $990,665 worth of shares (50,000 units at $19.81), increasing direct ownership by 3% to 1,800,213 units (SEC Form 4)

      4 - Remitly Global, Inc. (0001782170) (Issuer)

      11/7/23 8:06:47 AM ET
      $RELY
      Business Services
      Consumer Discretionary
    • Morris Nigel W bought $4,818,509 worth of shares (250,000 units at $19.27), increasing direct ownership by 17% to 1,750,213 units (SEC Form 4)

      4 - Remitly Global, Inc. (0001782170) (Issuer)

      11/6/23 7:36:09 AM ET
      $RELY
      Business Services
      Consumer Discretionary

    $DOCS
    $RELY
    $LVGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Monness Crespi & Hardt reiterated coverage on Remitly Global with a new price target

      Monness Crespi & Hardt reiterated coverage of Remitly Global with a rating of Buy and set a new price target of $32.00 from $30.00 previously

      5/8/25 7:31:41 AM ET
      $RELY
      Business Services
      Consumer Discretionary
    • Doximity upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded Doximity from Neutral to Overweight and set a new price target of $78.00 from $31.00 previously

      2/7/25 9:03:46 AM ET
      $DOCS
      EDP Services
      Technology
    • Doximity upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Doximity from Market Perform to Outperform and set a new price target of $90.00 from $60.00 previously

      2/7/25 6:59:36 AM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    $RELY
    $LVGO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Remitly Reports First Quarter 2025 Results Above Outlook and Raises Full Year 2025 Outlook

      First quarter send volume up 41% and revenue up 34% year over yearFirst quarter net income was $11.4 million and Adjusted EBITDA was $58.4 million SEATTLE, May 07, 2025 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY), a trusted provider of digital financial services that transcend borders, reported results for the first quarter ended March 31, 2025. "We delivered an outstanding start to the year, significantly exceeding our expectations for the first quarter," said Matt Oppenheimer, co-founder and Chief Executive Officer, Remitly. "This performance was driven by the deep and growing trust our customers place in us to deliver a fast, reliable, an

      5/7/25 4:05:00 PM ET
      $RELY
      Business Services
      Consumer Discretionary
    • Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

      Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2025 after market close on May 15, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members

      4/24/25 4:01:00 PM ET
      $DOCS
      EDP Services
      Technology
    • Remitly to Report First Quarter Financial Results on May 7, 2025

      SEATTLE, April 23, 2025 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly"), a trusted provider of digital financial services that transcend borders, today announced that it will report first quarter financial results after the market close on Wednesday, May 7, 2025. Management will host a conference call and live webcast to present the Company's financial results and answer questions from the financial analyst community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time that same evening. Conference call and webcast information can be found below. Remitly First Quarter Financial Results Conference Call and Webcast Information:When: Wednesday, May 7th, 2025Time: 2:00 p.m. P

      4/23/25 4:05:00 PM ET
      $RELY
      Business Services
      Consumer Discretionary

    $DOCS
    $RELY
    $LVGO
    SEC Filings

    See more
    • SEC Form 10-Q filed by Remitly Global Inc.

      10-Q - Remitly Global, Inc. (0001782170) (Filer)

      5/7/25 4:12:20 PM ET
      $RELY
      Business Services
      Consumer Discretionary
    • Remitly Global Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Remitly Global, Inc. (0001782170) (Filer)

      5/7/25 4:09:59 PM ET
      $RELY
      Business Services
      Consumer Discretionary
    • SEC Form 144 filed by Doximity Inc.

      144 - Doximity, Inc. (0001516513) (Subject)

      5/2/25 4:06:18 PM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    $RELY
    $LVGO
    Leadership Updates

    Live Leadership Updates

    See more
    • Define Ventures Appoints Carolyn Magill as Venture Partner

      The former Aetion and Remedy Partners CEO joins Define to further drive innovation across provider, payer, and pharmaceutical sectors SAN FRANCISCO, March 11, 2025 /PRNewswire/ -- Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Carolyn Magill, former CEO of Aetion, has joined the firm as venture partner. Magill, leveraging her 25 years of invaluable experience scaling companies and fostering innovation within payer, provider, and pharmaceutical organizations, will partner with Define founders to scale their companies and become category-defining companies.

      3/11/25 5:30:00 AM ET
      $EVH
      $HIMS
      $LVGO
      Other Consumer Services
      Consumer Discretionary
      Medical/Nursing Services
      Health Care
    • Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

      With its first-of-its-kind platform, Mendaera is pioneering a new category in medical robotics Mendaera, Inc., a Silicon Valley-based healthcare technology company developing a handheld robotic interventional platform, announced today the close of $73 million in Series B funding led by Threshold Ventures, with participation from investors including Lux Capital, PFM Health Sciences, and Fred Moll (founder of Intuitive Surgical and Auris Health). The financing will further Mendaera's efforts to scale robotics and AI across mainstream medical procedures. The healthcare system is facing an increasing supply and demand crisis, where the ability to consistently deliver high-quality care to pati

      9/26/24 6:05:00 AM ET
      $DOCS
      $RELY
      $LVGO
      EDP Services
      Technology
      Business Services
      Consumer Discretionary
    • Remitly Announces CFO Transition Plan

      SEATTLE, July 31, 2024 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY), a trusted provider of digital financial services that transcend borders, today announced the appointment of seasoned finance executive Vikas Mehta as Chief Financial Officer, succeeding Hemanth Munipalli, effective August 19, 2024. Munipalli is leaving for family reasons, and will oversee an orderly transition, remaining with the company through September 30, 2024. "I am delighted to welcome Vikas to Remitly as our Chief Financial Officer," said Matt Oppenheimer, Co-founder and CEO of Remitly. "Vikas's impressive track record leading finance functions at high-growth companies, experience driving public company

      7/31/24 6:00:00 PM ET
      $RELY
      Business Services
      Consumer Discretionary

    $DOCS
    $RELY
    $LVGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Doximity Inc.

      SC 13G/A - Doximity, Inc. (0001516513) (Subject)

      11/14/24 5:22:01 PM ET
      $DOCS
      EDP Services
      Technology
    • SEC Form SC 13G filed by Doximity Inc.

      SC 13G - Doximity, Inc. (0001516513) (Subject)

      11/14/24 11:42:53 AM ET
      $DOCS
      EDP Services
      Technology
    • SEC Form SC 13G filed by Remitly Global Inc.

      SC 13G - Remitly Global, Inc. (0001782170) (Subject)

      11/13/24 7:32:47 PM ET
      $RELY
      Business Services
      Consumer Discretionary

    $DOCS
    $RELY
    $LVGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Vice Chair Hug Joshua sold $841,954 worth of shares (40,000 units at $21.05), decreasing direct ownership by 1% to 3,773,811 units (SEC Form 4)

      4 - Remitly Global, Inc. (0001782170) (Issuer)

      5/7/25 4:46:14 PM ET
      $RELY
      Business Services
      Consumer Discretionary
    • Director Wampler Kira Scherer converted options into 2,000 shares and sold $113,853 worth of shares (2,000 units at $56.93) (SEC Form 4)

      4 - Doximity, Inc. (0001516513) (Issuer)

      5/2/25 4:19:42 PM ET
      $DOCS
      EDP Services
      Technology
    • Chief Financial Officer Bryson Anna converted options into 95,000 shares and sold $5,575,235 worth of shares (95,000 units at $58.69) (SEC Form 4)

      4 - Doximity, Inc. (0001516513) (Issuer)

      5/2/25 4:19:07 PM ET
      $DOCS
      EDP Services
      Technology

    $DOCS
    $RELY
    $LVGO
    Financials

    Live finance-specific insights

    See more
    • Doximity to Release Fiscal 2025 Fourth Quarter and Full Year Results on May 15, 2025

      Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2025 after market close on May 15, 2025. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members

      4/24/25 4:01:00 PM ET
      $DOCS
      EDP Services
      Technology
    • Remitly to Report First Quarter Financial Results on May 7, 2025

      SEATTLE, April 23, 2025 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ:RELY) ("Remitly"), a trusted provider of digital financial services that transcend borders, today announced that it will report first quarter financial results after the market close on Wednesday, May 7, 2025. Management will host a conference call and live webcast to present the Company's financial results and answer questions from the financial analyst community at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time that same evening. Conference call and webcast information can be found below. Remitly First Quarter Financial Results Conference Call and Webcast Information:When: Wednesday, May 7th, 2025Time: 2:00 p.m. P

      4/23/25 4:05:00 PM ET
      $RELY
      Business Services
      Consumer Discretionary
    • Doximity Announces Fiscal 2025 Third Quarter Financial Results

      Total revenues of $168.6 million, up 25% year-over-year Net income growth of 57% and adjusted EBITDA growth of 39% year-over-year Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 third quarter ended December 31, 2024. "We're proud to deliver another quarter of record engagement in Q3, with over 610,000 unique providers using our clinical workflow tools," said Jeff Tangney, co-founder and CEO of Doximity. "Our AI tools grew the fastest last quarter, up 60% over the prior quarter, while our newsfeed surpassed more than one million unique providers." Fiscal 2025 Third Quarter Financial Highlights All com

      2/6/25 4:01:00 PM ET
      $DOCS
      EDP Services
      Technology